Bayesian two-stage design for phase II clinical trials with switching hypothesis tests

DOI10.1214/15-BA988zbMath1384.62311OpenAlexW2221426840MaRDI QIDQ1699638

Guosheng Yin, Haolun Shi

Publication date: 23 February 2018

Published in: Bayesian Analysis (Search for Journal in Brave)

Full work available at URL: https://projecteuclid.org/euclid.ba/1450456405

zbMATH Keywords

expected sample sizetype I errortwo-stage proceduretype II errorphase II clinical trialBayesian error ratessingle-to-double arm design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Sequential statistical design (62L05)

Related Items (4)

Bayesian two-stage design for drug screening trials with switching hypothesis tests based on continuous endpoints ⋮ Stopping for efficacy in single-arm phase II clinical trials ⋮ Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials ⋮ Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials

This page was built for publication: Bayesian two-stage design for phase II clinical trials with switching hypothesis tests